SCOTIA CAPITAL INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.

Quarter-by-quarter ownership
SCOTIA CAPITAL INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$471,000
+18.3%
23,289
-7.0%
0.01%
+40.0%
Q1 2018$398,000
-85.4%
25,032
-80.9%
0.01%
-86.1%
Q4 2017$2,725,000
+784.7%
131,117
+508.5%
0.04%
+800.0%
Q3 2017$308,000
-58.8%
21,547
-50.2%
0.00%
-69.2%
Q2 2017$747,000
+77.0%
43,235
+12.8%
0.01%
+85.7%
Q1 2017$422,000
-81.4%
38,319
-75.6%
0.01%
-80.6%
Q4 2016$2,274,000
+11.5%
156,761
+88.5%
0.04%
-5.3%
Q3 2016$2,040,000
-73.0%
83,143
-77.8%
0.04%
-75.2%
Q2 2016$7,547,000
+189.4%
374,923
+277.6%
0.15%
+168.4%
Q1 2016$2,608,000
-51.7%
99,302
+86.7%
0.06%
-53.3%
Q4 2015$5,401,000
-8.5%
53,179
+60.8%
0.12%
-8.3%
Q3 2015$5,900,000
-26.9%
33,074
-10.3%
0.13%
-17.9%
Q2 2015$8,076,000
+49.2%
36,861
+34.5%
0.16%
+15.7%
Q1 2015$5,413,000
+172.6%
27,401
+97.2%
0.14%
+169.2%
Q4 2014$1,986,000
-85.8%
13,898
-87.0%
0.05%
-82.6%
Q3 2014$13,981,000
+10.1%
107,085
+6.1%
0.30%
+8.7%
Q2 2014$12,704,000
-55.9%
100,963
-54.0%
0.28%
-57.1%
Q1 2014$28,805,000
+9.5%
219,400
-2.2%
0.64%
+2.2%
Q4 2013$26,310,000
+33.6%
224,269
+18.6%
0.63%
+19.0%
Q3 2013$19,688,000
+188.8%
189,167
+138.7%
0.53%
+100.4%
Q2 2013$6,817,00079,2650.26%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2014
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders